Clinical Trials Directory

Trials / Sponsors / Hipra Scientific, S.L.U

Hipra Scientific, S.L.U

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
CompletedSafety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine
SARS-CoV2 Infection
Phase 2 / Phase 32023-11-15
CompletedA Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Infl
SARS CoV 2 Infection, Influenza, Human
Phase 22023-09-04
CompletedOpen-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of
SARS CoV 2 Infection
Phase 22023-06-08
CompletedA Phase IIb/III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immun
SARS CoV 2 Infection
Phase 2 / Phase 32022-05-12
CompletedAssessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated
COVID-19, SARS-CoV-2 Acute Respiratory Disease
Phase 22022-03-25
CompletedA Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against C
COVID-19, SARS-CoV-2 Acute Respiratory Disease
Phase 32022-02-03
CompletedImmunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SA
COVID-19, SARS-CoV-2 Acute Respiratory Disease
Phase 22021-11-16
CompletedSafety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-1
COVID-19, SARS-CoV-2 Acute Respiratory Disease
Phase 22021-11-11